{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:12:28Z","timestamp":1778843548484,"version":"3.51.4"},"reference-count":31,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2022,5,13]]},"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study aimed to investigate the anatomical and functional changes in patients with central retinal artery occlusion (CRAO) (n=21) treated with 10\u2009\u00b5g\/day intravenous liposomal prostaglandin E1 (lipo-PGE1).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>We used best-corrected visual acuity (BCVA), central retinal thickness with spectral domain optical coherence photography, optical intensity ratio (OIR) with imageJ software and retinal vessel diameter with fundus photography as indicators. Data were analysed using Tukey\u2019s multiple comparisons, Wilcoxon test or Spearman\u2019s correlation analysis as appropriate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>BCVA was significantly improved at 1\u2009month and 3 months after the initial visit (from 2.18\u00b10.60\u2009to 1.54\u00b10.84\u2009and 1.53\u00b10.88, p=0.030\u2009and p=0.027, respectively). The ratio of retinal vein diameter to optic disc diameter increased in the first month (from 0.40%\u00b10.13% to 0.52%\u00b10.16%, p=0.005). In addition, the OIR at the initial visit was significantly correlated with BCVA at 3 months (p=0.006, r=0.58). No severe adverse effects were observed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The results showed that visual acuity and retinal vein constriction improved after lipo-PGE1 therapy. In addition, the OIR in the initial phase can be an indicator of visual prognosis after treatment with PGE1 in patients with CRAO.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjophth-2022-001014","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T12:00:25Z","timestamp":1653480025000},"page":"e001014","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Intravenous lipo-prostaglandin E1 administration for patients with acute central retinal artery occlusion"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7385-415X","authenticated-orcid":false,"given":"Takafumi","family":"Suzuki","sequence":"first","affiliation":[{"name":"Shinseikai Toyama Hospital, Imizu, Toyama, Japan"},{"name":"The University of Tokyo Hospital, Bunkyo-ku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1762-0797","authenticated-orcid":false,"given":"Ryo","family":"Obata","sequence":"additional","affiliation":[{"name":"The University of Tokyo Hospital, Bunkyo-ku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Inoue","sequence":"additional","affiliation":[{"name":"The University of Tokyo Hospital, Bunkyo-ku, Japan"},{"name":"Yokohama City University, Yokohama, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Ueta","sequence":"additional","affiliation":[{"name":"Shinseikai Toyama Hospital, Imizu, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Azuma","sequence":"additional","affiliation":[{"name":"The University of Tokyo Hospital, Bunkyo-ku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Tate","sequence":"additional","affiliation":[{"name":"Shinseikai Toyama Hospital, Imizu, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohdai","family":"Kitamoto","sequence":"additional","affiliation":[{"name":"The University of Tokyo Hospital, Bunkyo-ku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"Otaki","sequence":"additional","affiliation":[{"name":"Shinseikai Toyama Hospital, Imizu, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Shinseikai Toyama Hospital, Imizu, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Aihara","sequence":"additional","affiliation":[{"name":"The University of Tokyo Hospital, Bunkyo-ku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Tachi","sequence":"additional","affiliation":[{"name":"Shinseikai Toyama Hospital, Imizu, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"2025090109191314000_7.1.e001014.1","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.2147\/OPTH.S232560","article-title":"Intra-arterial thrombolysis for central retinal artery occlusion","volume":"13","author":"Hakim","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"2025090109191314000_7.1.e001014.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(99)00359-1"},{"key":"2025090109191314000_7.1.e001014.3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ncpneuro0811","article-title":"Management of acute central retinal artery occlusion","volume":"4","author":"Chen","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"2025090109191314000_7.1.e001014.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2012.04.008"},{"key":"2025090109191314000_7.1.e001014.5","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1755-3768.1969.tb08157.x","article-title":"Occlusion of the central retinal artery","volume":"47","author":"Lorentzen","year":"1969","journal-title":"Acta Ophthalmol"},{"key":"2025090109191314000_7.1.e001014.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)76167-7"},{"key":"2025090109191314000_7.1.e001014.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(95)30758-0"},{"key":"2025090109191314000_7.1.e001014.8","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.613653"},{"key":"2025090109191314000_7.1.e001014.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.03.061"},{"key":"2025090109191314000_7.1.e001014.10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.037135"},{"key":"2025090109191314000_7.1.e001014.11","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200408000-00006"},{"key":"2025090109191314000_7.1.e001014.12","first-page":"S31","article-title":"Treatment of vascular retinal disease with pentoxifylline: a controlled, randomized trial","volume":"53 Suppl 1","author":"Incandela","year":"2002","journal-title":"Angiology"},{"key":"2025090109191314000_7.1.e001014.13","first-page":"1301","article-title":"Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment","volume":"23","author":"Schmidt","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025090109191314000_7.1.e001014.14","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.10.2076"},{"key":"2025090109191314000_7.1.e001014.15","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1991.01080030041034"},{"key":"2025090109191314000_7.1.e001014.16","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.64.12.913"},{"key":"2025090109191314000_7.1.e001014.17","first-page":"285","article-title":"A clinical study of Fifty-four cases of occlusion of the central artery of the retina and its branches: (Section of ophthalmology)","volume":"30","author":"Minton","year":"1937","journal-title":"Proc R Soc Med"},{"key":"2025090109191314000_7.1.e001014.18","first-page":"1","article-title":"Occlusion of the central retinal artery and retinal branch arterioles. A clinical, tonographic and fluorescein angiographic study of 175 patients","volume":"109","author":"Karjalainen","year":"1971","journal-title":"Acta Ophthalmol Suppl"},{"key":"2025090109191314000_7.1.e001014.19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40256-014-0100-5","article-title":"A systematic review of aspirin in primary prevention: is it time for a new approach?","volume":"15","author":"Brotons","year":"2015","journal-title":"Am J Cardiovasc Drugs"},{"key":"2025090109191314000_7.1.e001014.20","first-page":"63","article-title":"Roles of vasodilatory prostaglandins in mitogenesis of vascular smooth muscle cells","volume":"48","author":"Schr\u00f6r","year":"1997","journal-title":"Agents Actions Suppl"},{"key":"2025090109191314000_7.1.e001014.21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/09537104.2012.661107","article-title":"Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin","volume":"24","author":"Kreutz","year":"2013","journal-title":"Platelets"},{"key":"2025090109191314000_7.1.e001014.22","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-11445"},{"key":"2025090109191314000_7.1.e001014.23","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3928\/23258160-20190108-02","article-title":"Intravenous prostaglandin E1 infusion for acute central retinal artery occlusion","volume":"50","author":"Malbin","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"2025090109191314000_7.1.e001014.24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2169\/internalmedicine.40.265","article-title":"Overlap syndrome with cerebral hemorrhage caused by prostaglandin E1 infusion","volume":"40","author":"Nonomura","year":"2001","journal-title":"Intern Med"},{"key":"2025090109191314000_7.1.e001014.25","first-page":"917","article-title":"A comparison of the effect of lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats","volume":"12","author":"Goto","year":"1986","journal-title":"Drugs Exp Clin Res"},{"key":"2025090109191314000_7.1.e001014.26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0090-6980(93)90081-H","article-title":"Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers","volume":"46","author":"Toyota","year":"1993","journal-title":"Prostaglandins"},{"key":"2025090109191314000_7.1.e001014.27","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1097\/IAE.0000000000001017","article-title":"Correlation of optical intensity on optical coherence tomography and visual outcome in central retinal artery occlusion","volume":"36","author":"Chen","year":"2016","journal-title":"Retina"},{"key":"2025090109191314000_7.1.e001014.28","doi-asserted-by":"crossref","first-page":"376.e1","DOI":"10.1016\/j.ajo.2005.03.038","article-title":"Central retinal artery occlusion: visual outcome","volume":"140","author":"Hayreh","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"2025090109191314000_7.1.e001014.29","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.85"},{"key":"2025090109191314000_7.1.e001014.30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/joim.12605","article-title":"Arterial ageing: from endothelial dysfunction to vascular calcification","volume":"281","author":"Tesauro","year":"2017","journal-title":"J Intern Med"},{"key":"2025090109191314000_7.1.e001014.31","doi-asserted-by":"publisher","DOI":"10.3109\/08037059409102274"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2022-001014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:19:26Z","timestamp":1756743566000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2022-001014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,5,25]]},"published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1136\/bmjophth-2022-001014"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2022-001014","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}